Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novavax

8.34
+0.47005.97%
Pre-market: 8.16-0.1800-2.16%07:27 EDT
Volume:5.07M
Turnover:42.07M
Market Cap:1.34B
PE:-6.77
High:8.48
Open:7.90
Low:7.87
Close:7.87
Loading ...
Sep 18, 2024

Proposed Sale Of Securities

Form 144 | NOVAVAX's Officer Filip Dubovsky proposes to sell 7335 Shares, with a total value of approximately $95331.
Aug 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 20, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jun 18, 2024

Proposed Sale Of Securities

Form144|Novavax Inc's Director James F.Young proposes to sell 15000 Shares, with a total value of approximately $205,650.
Jun 17, 2024

Proposed Sale Of Securities

Form144|Novavax's Officer Filip Dubovsky proposes to sell 13904 Shares, with a total value of approximately $201,185.
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]